
Article 1 

1. The derogation from mutual recognition proposed by France for the product referred to in paragraph 2 is justified on the grounds of the protection of health and life of humans, particularly of vulnerable groups, as referred to in Article 37(1)(c) of Regulation (EU) No 528/2012.
2. Paragraph 1 applies to the product identified by the following case number, as provided for by the Register for Biocidal Products:
 BC-QC011565-51.
Article 2 
This Decision is addressed to the Republic of France.
Done at Brussels, 10 May 2017.
For the Commission
Vytenis ANDRIUKAITIS
Member of the Commission